The recently rediscovered halogen bond phenomenon,^[@ref1]^ i.e., the weak, noncovalent interaction between an electron donor and an electron-poor region of a halogen, has been successfully exploited in crystal engineering,^[@ref2]^ supramolecular chemistry,^[@ref2]^ organocatalysis,^[@ref3]^ functional materials,^[@ref4]^ anion recognition,^[@ref5]^ and medicinal chemistry,^[@ref6]^ for example. It is being developed into a molecular tool that is an alternative to hydrogen bonding^[@ref7]^ and is expected to find applications in chemistry and drug discovery. The directionality and strength of halogen bonding can be tuned by changing the halogen atom (F ≪ Cl \< Br \< I).^[@ref2]^ Model studies in solutions have so far typically been performed on the halogen bonds of simplified, perfluorinated, small organic molecules, while studies in biomacromolecules are scarce.^[@ref8]^ Halogen bonds have been used in the modulation of binding of a ligand to various receptors,^[@ref6],[@ref9],[@ref10]^ to induce DNA junctions,^[@ref11]^ and in rational drug design,^[@ref12]^ but they have so far barely been applied in peptide and protein engineering.^[@ref13],[@ref14]^ Most investigations to date have been performed *in silico* and in the solid state, whereas solution studies of halogen bonds in a biological environment have lagged behind, most likely as the analysis of week interactions in non-ordered media is highly challenging. In very recent work by Ho and co-workers, the incorporation of a halogen bond donor amino acid analogue into lysozyme T4 resulted in a short iodine--oxygen contact in the solid state yet a simultaneous destabilization of the protein structure in solution.^[@ref13]^ Iodine substitution was shown to have a stabilizing effect as compared to another iodinated mutant. This highlights the challenge of developing a biopolymer-based model system in which the isolated effect of a weak halogen bond can be studied, with the additional interactions and geometries remaining unaffected.^[@ref15]^ Herein, we demonstrate, for the first time, the utility of halogen bonding in peptide chemistry in solution. We use it for conformational stabilization of a β-hairpin motif, to an extent comparable to that of an analogous interstrand hydrogen bond.

We have designed a peptide model system ([Figures [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}) that allows the investigation of a single weak interaction force, here a halogen bond, embedded in a complex, proteinlike environment. To measure its strength, we follow the change in the folding propensity of the peptide upon permitting or preventing the formation of this specific interaction \[R~3~--R~8~ ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"})\], as achieved by the minimal necessary structural alteration. Whereas the overall stability of the folded conformation is established by a series of cooperatively acting weak forces, it is modulated by the alteration of a single, conformation-stabilizing interaction. Studying a weak interaction in an intramolecular model system offers a crucial entropic advantage that permits the characterization of exceptionally weak forces.^[@ref16]^ We have previously proven this concept,^[@ref17],[@ref18]^ and we apply it herein for the exploration of the halogen bond in a biologically relevant model system.

![Chemical structure of the studied β-hairpin model system, with the R~3~--R~8~ interaction site (top), shown from above (bottom left) and from the side (bottom right).](bi-2017-004293_0001){#fig1}

![Schematic structure of the investigated cyclic β-hairpin peptides.](bi-2017-004293_0002){#fig2}

Experimental Details {#sec2}
====================

All experimental details are given in the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00429/suppl_file/bi7b00429_si_001.pdf).

Results and Discussion {#sec3}
======================

Design {#sec3.1}
------

Our model system ([Figures [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}) was designed to be comprised of two three-amino acid strands each, locating the interaction site of interest, R~3~--R~8~, on one face of the peptide and the side chains of all other amino acids of the β-strands on the opposite face, thereby avoiding unwanted side chain--side chain interactions. Connecting the strands with strong β-turn inducers^[@ref19],[@ref20]^ at both ends of the β-strands promotes β-hairpin folding and locates the donor and acceptor sites across from each other, in optimal geometry for interaction. The cyclic nature of the model system provides an entropic advantage and promotes β-hairpin folding,^[@ref21]^ which in turn is further supported by the incorporation of β-branched amino acids into the strands.^[@ref22]^ Amino acids with nonpolar side chains are also expected to form conformation-stabilizing interstrand hydrophobic interactions,^[@ref20]^ which in combination with weak backbone N--H···O=C hydrogen bonds provides an overall stability of the β-hairpin conformation. For evaluation of the β-hairpin content of the model systems, NAMFIS (nuclear magnetic resonance analysis of molecular flexibility in solution) ensemble analysis was used.^[@ref23],[@ref24]^ This combined nuclear magnetic resonance (NMR) spectroscopic and computational technique deconvolutes time-averaged spectroscopic data (NOE and ^3^*J*~CαH,NH~) to yield the ensemble that describes the solution conformations of flexible systems (*vide supra*). NAMFIS has previously been successfully utilized to determine the solution conformations of both peptides^[@ref17],[@ref25],[@ref26]^ and small molecules.^[@ref27],[@ref28]^

Prior to synthesis of a peptide possessing a halogen bond donor site, the system was optimized using an analogous sequence encompassing a hydrogen bond donor side chain functionality. First, peptides encompassing serine or *O*-methyl-[l]{.smallcaps}-serine as a hydrogen bond acceptor at position 8 and serine as a hydrogen bond donor at position 3 \[R~8~ = OH or OMe, and R~3~ = OH ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"} and [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, **1a** and **2a**)\] were synthesized. As references, analogous peptides were used in which the hydrogen bond donor OH of R~3~ was substituted with a CH~3~ group ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, **1b** and **2b**). The CH~3~ group is of comparable size yet prevents the formation of an attractive R~3~--R~8~ interaction. Upon formation of a stabilizing interchain interaction, here a hydrogen (R~3~ = OH) or a halogen (R~3~ = Cl/Br) bond, the peptide is expected to show β-hairpin folding propensity higher than that of the corresponding reference (R~3~ = CH~3~) that lacks this interaction. The difference in folding propensity of the hydrogen or halogen bond-forming peptide and the references consequently reflects the strength of the R~3~--R~8~ interaction.

###### Peptides Evaluated Using NAMFIS Analysis

                                           peptide sequence[d](#t1fn4){ref-type="table-fn"}   R~3~[e](#t1fn5){ref-type="table-fn"}   R~8~   *n*   \% β-hairpin[f](#t1fn6){ref-type="table-fn"}
  ---------------------------------------- -------------------------------------------------- -------------------------------------- ------ ----- ----------------------------------------------
  **1a**[a](#t1fn1){ref-type="table-fn"}   c(NVSAGD-PVSQG)                                    OH                                     OH     1     88
  **1b**[a](#t1fn1){ref-type="table-fn"}   c(NVXAGD-PVSQG)                                    Me                                     OH     1     50
  **2a**[b](#t1fn2){ref-type="table-fn"}   c(NVSAGD-PVS(Me)QG)                                OH                                     OMe    1     58
  **2b**[b](#t1fn2){ref-type="table-fn"}   c(NVXAGD-PVS(Me)QG)                                Me                                     OMe    1     29
  **3a**[c](#t1fn3){ref-type="table-fn"}   NVSAGD-PVhS(Me)QG-Ac                               OH                                     OMe    2     11
  **3b**[c](#t1fn3){ref-type="table-fn"}   NVXAGD-PVhS(Me)QG-Ac                               Me                                     OMe    2     0
  **4a**[c](#t1fn3){ref-type="table-fn"}   c(GQSAGD-PVhS(Me)AN)                               OH                                     OMe    2     36
  **4b**[c](#t1fn3){ref-type="table-fn"}   c(GQXAGD-PVhS(Me)AN)                               Me                                     OMe    2     31
  **5**[c](#t1fn3){ref-type="table-fn"}    c(NVA(Cl)AGD-PVS(Me)QG)                            Cl                                     OMe    1     74
  **8**[c](#t1fn3){ref-type="table-fn"}    c(NVA(Br)AGD-PVS(Me)QG)                            Br                                     OMe    1     --

Synthesis and characterization.^[@ref17]^

Synthesis and characterization.^[@ref29]^

Synthesis and characterization described in the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00429/suppl_file/bi7b00429_si_001.pdf).

The peptide sequence is given according to the numbering in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}. X = ABU (2-aminobutanoic acid). S(Me) = *O*-methyl-[l]{.smallcaps}-serine. hS(Me) = *O*-methyl-[l]{.smallcaps}-homoserine.

OH substitution at position 3 allows a hydrogen cross strand interaction with position 8. When position 3 is substituted with CH~3~, this interaction is not possible, and the CH~3~-substituted analogue serves as a reference.

The % β-hairpin in solution as determined by NAMFIS analysis. Peptide **8** could not be evaluated via NAMFIS because of rapid degradation at room temperature.

To explore the geometrical factors influencing the overall β-hairpin stability and the efficiency of the R~3~--R~8~ interaction, a series of peptides possessing either a hydrogen bond donor (R~3~ = OH, **1a--4a**) or a non-interacting reference (R~3~ = CH~3~, **1b--4b**) at position 3 were designed ([Figures [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"} and [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). The cyclic peptides **1a** and **1b** have shown a high β-hairpin folding propensity that was efficiently modulated by the presence or absence of the R~3~--R~8~ interstrand hydrogen bond \[[Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}; **1a**, OH···O(H), 88% β-hairpin; **1b**, CH~3~··/··O(H), 50% hairpin\].^[@ref17]^ Replacement of the R~8~ OH of **1a** and **1b** with OCH~3~, yielding peptides **2a** and **2b**, respectively, prevents formation of a competing hydrogen bonding interaction in which R~8~ acts as a Lewis acid, instead of acting only as a Lewis base, which is a necessity for the halogen bond analogue. This change resulted in an ∼30% decrease in the overall level of folding (**2a** vs **1a**). The R~3~--R~8~ hydrogen bond-forming peptide **2a** showed a level of folding ∼30% higher than that of reference system **2b**, which does not permit an attractive interstrand side chain interaction. The 29--58% overall stability of **2a** and **2b** as compared to that of **1a** and **1b** (50--88%) puts the model system into the folding region that is most sensitive for detection of small changes, within a two-state equilibrium.

To evaluate whether an increased overall flexibility could promote a more optimal geometry for formation of an interstrand R~3~--R~8~ interaction, expected to provide an even larger difference in folding of the hydrogen bonding and the reference systems, peptides **2a** and **2b** were converted into their acyclic analogues. In addition, the side chain of amino acid R~8~ was extended with a methylene group ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, **3a** and **3b**, *n* = 2); i.e., a [l]{.smallcaps}-serine to [l]{.smallcaps}-homoserine substitution was performed at position 8. In this case, a substantial destabilization of the β-hairpin conformation was observed, which is in good agreement with previous reports suggesting cyclization to be an efficient tool in stabilizing the hairpin conformation of small, flexible peptides.^[@ref21]^ In addition, the amino acid sequence of **2a** and **2b** was altered to decrease backbone rigidity, yielding the cyclic analogues **4a** and **4b**, respectively, with the extended R~8~ side chain (*n* = 2). Although the observed β-hairpin content was higher than for acyclic **3a** and **3b**, the increased flexibility did not facilitate a geometry permitting a stronger R~3~--R~8~ hydrogen bond and thus decreased the overall level of folding as well as the difference in folding of the hydrogen bond forming **4a** and the reference **4b**. On the basis of the collected information, we have synthesized analogues of peptide **2a** that possess a chlorine (**5**) or bromine (**8**) halogen bond donor functionality in the side chain of R~3~ and the halogen bond acceptor OCH~3~ at R~8~. The impact of an interstrand halogen bond was studied by NMR ensemble analysis in solution, proving the applicability of the halogen bond in peptide and protein engineering and providing a quantitative measure of the relative strength of a halogen bond as compared to an analogous hydrogen bond, **2a**, using the non-interacting peptide **2b** as a reference.

Synthesis {#sec3.2}
---------

The synthesis of peptide **5**, encompassing β-chloroalanine in position 3, is summarized in [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}. Its linear precursor **6** was prepared by automated solid phase peptide synthesis with a PS3 peptide synthesizer utilizing the Fmoc-*t*-Bu-Trt protecting strategy^[@ref30],[@ref31]^ with TBTU as the coupling reagent and diisopropylethylamine as the base on 2-chlorotrityl resin. Following the coupling of the first eight amino acids, the last two were performed manually under conditions carefully optimized to avoid elimination of the chlorine atom (for details, see the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00429/suppl_file/bi7b00429_si_001.pdf)) using HATU as a coupling reagent in combination with TMP. Cleavage of the linear decapeptide from the resin was performed with 1% trifluoroacetic acid in dichloromethane, followed by cyclization utilizing a pseudo-high-dilution procedure^[@ref32]^ with HATU as the coupling reagent in the presence of TMP. Removal of protecting groups and subsequent purification by RP-HPLC using a C18 column afforded **5** in an overall yield of 18%. The synthesis of peptide **8**, encompassing β-bromoalanine at position R~3~, is summarized in [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}. As the aliphatic carbon--bromine bond is unstable under the conditions of peptide coupling and deprotection, the bromine atom was introduced in the last step of the synthesis by transformation of the S3 hydroxy group of the fully unprotected peptide **2a** with the Vilsmeier reagent. This reagent was prepared from phosphorus tribromide and DMF at 0 °C^[@ref33]^ and was added to the peptide in the presence of sodium bromide at room temperature in DMF as a solvent.^[@ref34]^ It should be noted here that this is the very first use of this synthetic strategy for introduction of bromine functionality into a peptide. This may then be used as a handle for introduction of further functionalities or to study halogen bonding, for example. The method is mild and substitutes an aliphatic hydroxyl group with bromine in a solvent in which many peptides are soluble. Peptide **8** was stored and studied by NMR spectroscopy at temperatures below −10 °C as it was found to rapidly degrade at room temperature in solution. Details of the synthesis of the peptides used for sequence optimization are given in the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00429/suppl_file/bi7b00429_si_001.pdf).

![Outline of the Synthesis of Peptide **5** Encompassing a β-Chloroalanine as a Halogen Bond Donor and *O*-Methylserine as a Halogen Bond Acceptor](bi-2017-004293_0006){#sch1}

![Synthesis of Peptide **8**, Encompassing an Aliphatic Bromine Halogen Bond Donor Functionality, Starting from Peptide **2a**](bi-2017-004293_0007){#sch2}

NMR Structural Assignment {#sec3.3}
-------------------------

This process was performed by the TOCSY-NOESY sequential backbone walk strategy.^[@ref35]^ Because of the low aqueous solubility of these peptides, similar to numerous other studies of β-hairpins,^[@ref17],[@ref29],[@ref36]−[@ref44]^ which typically occur in the hydrophobic core of proteins that is much less polar than water,^[@ref45]^ DMSO-*d*~6~ was chosen as the solvent. For peptide **5**, the chemical shifts of the H~α~s \[δ~Hα~ ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}); for the full assignment see the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00429/suppl_file/bi7b00429_si_001.pdf)\] and the magnitude of the ^3^*J*~CαH,NH~ scalar couplings^[@ref46],[@ref47]^ were in agreement with the expected β-hairpin conformation.^[@ref48]^ The amide temperature coefficients, Δδ~NH~/Δ*T* ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}), indicate formation of strong intramolecular hydrogen bonds involving the amide protons of A4 and Q9, confirming the two β-turns illustrated with red boxes in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}. In line with the expectations, the intermediate Δδ~NH~/Δ*T* values of V2 and V7 indicate that these amide protons are involved in labile intramolecular hydrogen bonds that are in equilibrium with hydrogen bonds in which the solvent acts as an electron donor. The high coefficients of the amides N1, A(Cl)3, S(Me)8, and G10 reflect the fact that these are solvent accessible and do not form intramolecular hydrogen bonds, in agreement with the expected β-hairpin conformation.

###### Chemical Shifts (δ~Hα~), Amide Proton Temperature Coefficients (Δδ~NH~/Δ*T*, 298--323 K), and Scalar Couplings (^3^*J*~CαH,NH~) for Peptide **5**, Obtained in a DMSO-*d*~6~ Solution

  residue position   δ~Hα~ (ppm)   Δδ~NH~/Δ*T* (ppb/K)[a](#t2fn1){ref-type="table-fn"}   ^3^*J*~CαH,NH~ (Hz)
  ------------------ ------------- ----------------------------------------------------- ---------------------
  N1                 4.07          6.52                                                  6.75
  V2                 4.19          3.44                                                  8.44
  A(Cl)3             5.25          5.20                                                  8.45
  A4                 4.66          1.28                                                  8.28
  G5                 3.84; 3.39    3.40                                                  --
  P6                 4.29          --                                                    --
  V7                 4.30          3.48                                                  7.98
  S(Me)8             4.80          5.36                                                  7.80
  Q9                 4.53          1.68                                                  8.44
  G10                3.84; 3.25    6.68                                                  --

A Δδ~NH~/Δ*T* value of \<3 indicates a strong intramolecular hydrogen bond. A Δδ~NH~/Δ*T* value of 3--5 indicates that the amide proton is in equilibrium between a solvent-exposed and an intramolecular hydrogen bond. A Δδ~NH~/Δ*T* value of \>5 indicates that the amide proton is solvent-exposed.^[@ref49]^

![Key NOE correlations (blue arrows) and backbone intramolecular hydrogen bonds (red boxes) observed for **5** in a DMSO-*d*~6~ solution. The cross strand NOEs indicate β-hairpin to be the predominant conformer of **5** in solution. See the details in the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00429/suppl_file/bi7b00429_si_001.pdf).](bi-2017-004293_0003){#fig3}

Peptide **8**, containing bromine as the halogen bond donor functionality at R~3~, was assigned following the same strategy as **5**, however, at −10 °C in a DMF-*d*~7~ solution (for assignments and details, see the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00429/suppl_file/bi7b00429_si_001.pdf)). As it was found to rapidly decompose above −10 °C, its amide temperature coefficients could not be reliably determined in DMSO-*d*~6~ for comparison to those of **2a**, **2b**, and **5**.

NOESY Buildups {#sec3.4}
--------------

These were acquired with mixing times of 200, 300, 400, 500, 600, and 700 ms without solvent suppression. Interproton distances for **5** ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}) were calculated according to the initial rate approximation from the linear part of the buildups (*r*^2^ \> 0.98) using the N1β1 and N1β2 geminal protons as an internal distance reference (1.78 Å). In total, 63 NOE correlations were observed (key correlations are shown in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}). Peptide **8** did not show any interstrand NOE correlations, with the spectra obtained at −10 °C in a DMF-*d*~7~ solution, suggesting that under these conditions it is unfolded in solution.

Solution Conformations of **5** {#sec3.5}
-------------------------------

These were identified like those of **1a--4b** were ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}), using NAMFIS analysis.^[@ref23]^ It should be noted that the conformation of flexible molecular systems cannot be accurately described with a single structure, but rather by deconvolution of their time-averaged spectroscopic data into probability-weighted geometries that are present in solution. Hence, NOESY buildup-based interproton distances and ^3^*J*~CαH,NH~-based dihedral angles were fitted to those back-calculated for the conformers of a computationally generated theoretical ensemble. Interproton distances were derived from NOE buildups as described above, and backbone dihedral angles were derived from ^3^*J*~CαH,NH~ scalar couplings using a Karplus equation specifically developed for peptides.^[@ref47],[@ref50]^ The theoretical ensemble was computed using restraint-free Monte Carlo conformational searches with intermediate torsion sampling and molecular mechanics energy minimization (MCMM) of each generated structure. For **1--4** ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}), the conformational search was performed twice, using the OPLS-2005 and AMBER\* force fields, as implemented in Macromodel version 9.1. For **5**, it was also performed with OPLS-3,^[@ref51]^ the first force field also parametrized for halogen bonds of aromatic halogen bond donors. For all computations, geometries within 42 kJ/mol of the global minimum were retained. Output conformations from the calculations using different force fields were combined, and the redundant ones were eliminated to yield a final ensemble that was used as input for the NAMFIS analysis. On the basis of the experimental distance and dihedral data, the probability of the theoretically available individual conformations was estimated (for details about the NAMFIS analysis, see the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00429/suppl_file/bi7b00429_si_001.pdf)). The folded β-hairpin conformations of **5** were identified to have 74% probability in solution. This is significantly higher than that observed for the reference peptide **2b** (R~3~ = CH~3~, 29%). Selected conformers deduced by the NAMFIS analysis are shown in [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}, whereas all geometries identified to be present in solution are given in the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00429/suppl_file/bi7b00429_si_001.pdf).

![Selected solution conformers of **5**, identified by NAMFIS analysis. (a) β-Hairpin conformation with a halogen bond formed at the R~3~--R~8~ interaction site (green). The total β-hairpin content was estimated to be 74%. (b) Non-β-hairpin conformer of **5**. All conformers deduced by NAMFIS are given in [Table S21 and Figure S11](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00429/suppl_file/bi7b00429_si_001.pdf). Hydrogen bonds are colored gray; aliphatic protons were omitted for the sake of clarity.](bi-2017-004293_0004){#fig4}

As all orientations of flexible peptide side chains cannot be expected to be well represented in a Monte Carlo conformational search, to obtain the most accurate results, the NAMFIS analysis was based on the NMR data of the backbone protons only. Importantly, even these analyses identify the conformation in which the R~3~--R~8~ interstrand hydrogen bond is formed, as the major one for **1a** and **2a**.^[@ref17],[@ref29]^ As none of the currently available force fields are parametrized for halogen bonds of aliphatic halogen bond donors, the molecular mechanics minimization selects conformations for **5** in which the chlorine of R~3~ avoids approaching the OCH~3~ of R~8~. To compensate for this shortcoming of the force field, a conformation optimized with a constrained Cl--OCH~3~ distance that is 90% of the sum of the van der Waals radii of the interacting atoms (2.94 Å ± 10%) and a restrained C--Cl--O angle of 180° ± 10% was also included in the ensemble for the NAMFIS analysis. This conformer encompasses a halogen bond with a theoretically optimal bond angle and bond length. It was identified by NAMFIS to exist in solution, which confirms that the formation of a halogen bond is compatible with the experimental data. Importantly, the incorporation of this conformer encompassing "optimal halogen bond geometry" into the NAMFIS analysis was not necessary for the evaluation of peptide folding. It was, however, included to compensate for a known weakness of the applied force field and to allow the assessment of whether the halogen-bonded peptide geometry is compatible with the experimental data.

For specific evaluation of the R~3~ and R~8~ side chain orientation of **5**, to gain an understanding of whether the Cl···O halogen bond is formed, we have performed a NAMFIS analysis using the NMR data of these residues only, along with theoretical data back-calculated for conformations constrained to have all possible low-energy orientations, i.e., gauche^+^, gauche^--^, and trans for the involved Cα--Cβ bonds (for details, see the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00429/suppl_file/bi7b00429_si_001.pdf), with the conformations shown in [Figure S12](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00429/suppl_file/bi7b00429_si_001.pdf) and the experimental and back-calculated distances listed in [Table S29](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00429/suppl_file/bi7b00429_si_001.pdf)). NAMFIS calculations based on experimental NOE data, with permutation of all possible assignments of the β-hydrogens of both amino acid side chains, reliably identified the side chain orientations (92%) that promote formation of a Cl···O halogen bond ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}a) in the dominant conformer. This analysis shows that the orientation of the R~3~ and R~8~ side chain permits the formation of a Cl···O halogen bond.

The chemical shift of nuclei in the direct neighborhood of an equilibrium process is expected to show a comparably high temperature dependence, because equilibrium constants describing dynamic processes are temperature-dependent, as described by the van't Hoff equation. Accordingly, the chemical shift of identical residues of structurally highly similar molecules is a useful reporter tool for identification of nearby equilibrium processes. We have monitored the temperature dependence of the chemical shift of the OCH~3~ protons of the R~8~ side chain of **2a**, **2b**, and **5** in the temperature interval of 298--373 K. The obtained NMR data corroborate the conclusion that **2b** and **5** form interstrand hydrogen and halogen bonds, respectively, between their R~3~ and R~8~ side chains as the temperature dependence of their OCH~3~ protons is significantly higher (Δδ/Δ*T* values for **2a** of 0.19 ppm/K and for **5** of 0.32 ppm/K) than that of the OCH~3~ of **2b** (Δδ/Δ*T* value for **2b** of 0.07 ppm/K), with the latter peptide possessing a non-interacting CH~3~ at position 3.

We have also performed variable-temperature NMR measurements to detect the melting curve describing the thermodynamic stability of the β-hairpin of peptides **2a**, **2b**, and **5**. To avoid extensive signal overlaps and to detect comparably large chemical shift changes, we have incorporated a ^13^C isotope at the β-carbon of alanine 7, permitting the selective detection of its chemical shift within minutes. Analysis of these data has, however, revealed that the chemical shift of a single nucleus in a peptide does not reliably reflect the overall folding of a peptide but may instead be dominantly reporting on local geometrical changes.^[@ref29]^ Therefore, these data were not used to characterize the relative thermodynamic stability of the folded conformation of the studied peptides.

Quantum Chemical Computations {#sec3.6}
-----------------------------

These were performed to assess the possibility of Cl···O interaction in **5**. The computational cost for a comprehensive investigation of the low-energy conformations of **5** with density functional theory (DFT) would have been prohibitive; therefore, the bonding situation was analyzed on the basis of a simplified model (see the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00429/suppl_file/bi7b00429_si_001.pdf) for details). The calculated Cl···O bond length of 3.291 Å and C--Cl···O bond angle of 173.1° for the Me~2~O···ClCH~3~ dimer indicate that the analogous S(Me)8 and A(Cl)3 side chains of **5** should allow for some halogen bonding, which was further corroborated by the results from a previous high-level *ab initio* calculation for H~2~CO···ClCH~3~ (3.26 Å, 166.8°).^[@ref52]^ The computed molecular electrostatic potential surface indicates the existence of a slightly positive region, i.e., a σ-hole, on the chlorine ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}).

![(a) Computed surface electrostatic potential of (b) β-chloroalanine indicating the presence of a σ-hole, i.e., a slightly positive region on the chlorine atom, promoting the formation of a halogen bond. The surface was computed on the 0.004 au contour of the electronic density. Color ranges are as follows: red, less than −50 kJ mol^--1^; yellow, between −50 and −3 kJ mol^--1^; green, between −30 and −20 kJ mol^--1^; light blue, between −20 and 0 kJ mol^--1^; and blue, greater than 0 kJ mol^--1^.](bi-2017-004293_0005){#fig5}

To estimate the stabilization energy provided by the Cl···O interaction, we reoptimized one of the (OPLS-3^[@ref51]^) equilibrium geometries of **5** using a two-layer ONIOM^[@ref53]^ procedure, treating the residues involved in the interaction by DFT and the remaining residues on the PM6 level.^[@ref54]^ The pair of residues S(Me)8 and A(Cl)3 were then isolated from the DFT geometry, and the energies of the S(Me)8···A(Cl)3 dimer and of the residues S(Me)8 and A(Cl)3 were estimated separately, with all geometries kept frozen. This procedure gave a bond energy of 41.2 kJ mol^--1^ for the S(Me)8 and A(Cl)3 interaction. This value is, however, dominated by the two hydrogen bonds between the residues. To isolate the contribution of the Cl···O bond, the chlorine atom in A(Cl)3 was replaced with a hydrogen atom, whose position was reoptimized while the rest of the system remained frozen. The bond energy between the two residues was recalculated, yielding a value of 35.1 kJ mol^--1^. Thus, the pure Cl···O bond energy contribution is estimated to be 41.2 -- 35.1 = 6.1 kJ mol^--1^. The actual halogen bond energy contribution is expected to be slightly smaller as there is probably some dispersion interaction between the Cl in A(Cl)3 and one of the methyl H atoms in S(Me)8. Thus, this value is in good agreement with the literature (4.4 kJ/mol)^[@ref52]^ and with the experimental finding that there is a weak conformation stabilizing Cl···O interaction in **5**.

Conclusion {#sec4}
==========

Folded peptides are mini-proteins that are common model systems for assessing the fundamental determinants of protein folding and stability.^[@ref55]^ Using a 10-amino acid model system, the chlorine-centered halogen bond was demonstrated to provide conformational stabilization comparable to that of an analogous hydrogen bond, proving the applicability of the halogen bond in protein engineering. This is the first peptide/protein system in which a halogen bond was rationally incorporated and shown to improve the stability of the folded conformation in solution. The sensitivity of the applied technique for detecting weak interactions is reflected by its ability to observe the influence of a weak, chlorine-centered halogen bond. For peptide **5**, the Cl···O halogen bond increases the molar fraction of the folded β-hairpin conformation by 44%, as compared to that of peptide **2b**, in which no interstrand R~3~--R~8~ interaction is promoted. Because of the poor NMR properties of chlorine, the halogen bond interaction could not be directly detected but was deduced to exist on the basis of NOE distance analysis (NAMFIS) and variable-temperature measurements of the OCH~3~ protons on the R~8~ halogen bond acceptor. The formation of a halogen bond is the most plausible explanation for the observed thermodynamic stability of **5** being higher than that of **2b**. The computed Cl···O bond energy is in good agreement with the experimental findings. Chlorine may be involved in van der Waals interactions, however, not significantly stronger than the analogous methyl functionality of **2b** at its R~3~. We have not observed formation of a bromine-centered halogen bond, which is most likely attributable to the larger size of bromine. Hence, formation of a bromine-centered, linear halogen bond in **8** may require an altered side chain orientation as compared to **5** that may be available for this peptide only with a significant energetic cost, or in a conformation that does not permit formation of interstrand N--H···O=C or hydrophobic side chain--side chain interactions. Synthesis of an analogue encompassing an iodine halogen bond donor was not attempted as the aliphatic C--I bond was expected to have a chemical stability even lower than that of the C--Br bond of **8**. The comparable conformation stabilizing ability of a chlorine-centered halogen bond to a hydrogen bond is remarkable. This may also be due to a R~3~--R~8~ side chain distance and an orientation that provides better geometry for formation of a weak halogen (**5**) than a weak hydrogen (**2a**) bond. The applicability of halogen bonding in peptide/protein engineering needs to be explored further to gain a detailed understanding of all steric and electronic factors that are of essential importance for the rational use of this so far unexplored molecular force in structural biology and drug discovery. Our experimental data will also be helpful for the parametrization of computational force fields to describe halogen bonding.

Halogen bonds are expected to be widely applicable in medicinal chemistry and protein engineering far beyond the modulation of conformational stability. They may, for example, be utilized in rational drug discovery to modulate the affinity and selectivity of molecular recognition events. Moreover, halogen bonding will likely be useful for the modulation of protein--protein interactions for which model studies of peptide and protein model systems in solution are of greatest significance.

We have developed a distinct model system that allows investigation of a specific weak interaction force in a complex molecular system. It has been carefully optimized to facilitate the investigation of any type of weak chemical force in a biologically relevant environment in solution, with its true potential being demonstrated here for the first time, through a comparative study of the halogen and the hydrogen bonds.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acs.biochem.7b00429](http://pubs.acs.org/doi/abs/10.1021/acs.biochem.7b00429).Details of the synthesis, spectroscopic data for compound identification, and details of the NMR and computational investigations ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00429/suppl_file/bi7b00429_si_001.pdf))
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DMF

:   dimethylformamide

DMSO

:   dimethyl sulfoxide

HATU

:   1-\[bis(dimethylamino)methylene\]-1*H*-1,2,3-triazolo\[4,5-*b*\]pyridinium 3-oxide hexafluorophosphate

RP-HPLC

:   reversed phase high-pressure liquid chromatography

TBTU

:   *N*′-tetramethyluronium tetrafluoroborate

TMP

:   2,4,6-trimethylpyridine.
